(2R,3R,4R,5S)-2-methyl-3,4,5-tris(phenylmethoxy)-1-(spiro[2.5]octan-6-ylmethyl)piperidine
C36H45NO3 — CID 155721114
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R,3R,4R,5S)-2-methyl-3,4,5-tris(phenylmethoxy)-1-(spiro[2.5]octan-6-ylmethyl)piperidine
(2R,3R,4R,5S)-2-methyl-3,4,5-tris(phenylmethoxy)-1-(spiro[2.5]octan-6-ylmethyl)piperidine (PubChem CID 155721114) has the molecular formula C36H45NO3 and a molecular weight of 539.76 g/mol. Its IUPAC name is (2R,3R,4R,5S)-2-methyl-3,4,5-tris(phenylmethoxy)-1-(spiro[2.5]octan-6-ylmethyl)piperidine.
Molecular Properties
| Compound Name | (2R,3R,4R,5S)-2-methyl-3,4,5-tris(phenylmethoxy)-1-(spiro[2.5]octan-6-ylmethyl)piperidine |
|---|---|
| PubChem CID | 155721114 |
| Molecular Formula | C36H45NO3 |
| Molecular Weight | 539.76 g/mol |
| Exact Mass | 539.34 |
| IUPAC Name | (2R,3R,4R,5S)-2-methyl-3,4,5-tris(phenylmethoxy)-1-(spiro[2.5]octan-6-ylmethyl)piperidine |
| SMILES | C[C@@H]1[C@@H](OCc2ccccc2)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)CN1CC1CCC2(CC1)CC2 |
| InChI | InChI=1S/C36H45NO3/c1-28-34(39-26-31-13-7-3-8-14-31)35(40-27-32-15-9-4-10-16-32)33(38-25-30-11-5-2-6-12-30)24-37(28)23-29-17-19-36(20-18-29)21-22-36/h2-16,28-29,33-35H,17-27H2,1H3/t28-,33+,34-,35-/m1/s1 |
| InChIKey | QGMIQSDUDZZLKE-JQGOHGDASA-N |
| XLogP | 7.42 |
| TPSA | 30.93 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 539.76 |
| LogP ≤ 5 | 7.42 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155721114 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.